TrialCancer chemotherapy and pharmacology2015

Pharmacokinetics of eribulin mesylate in cancer patients with normal and impaired renal function.

Antoinette R Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.